Inventor
RENNEBERG DORTE
SE18 patents
⚠️ This page may combine multiple inventors who share the name “RENNEBERG DORTE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HILPERT KURT
5 patentsUS9221832B2Dec 29, 2015
Heterocyclic amide derivatives as P2X7 receptor antagonists
HILPERT KURT6 citations71
US8202885B2Jun 19, 2012
Bridged six-membered ring compounds
HILPERT KURT7 citations71
US9409917B2Aug 9, 2016
Heterocyclic amide derivatives as P2X7 receptor antagonists
HILPERT KURT0 citations39
US8436205B2May 7, 2013
Tetrahydronaphthalene compounds
HILPERT KURT0 citations39
US8314253B2Nov 20, 2012
Bridged tetrahydronaphthalene derivatives
HILPERT KURT0 citations39
CAROFF EVA
4 patentsUS8518912B2Aug 27, 2013
Phosphonic acid derivates and their use as P2Y12 receptor antagonists
CAROFF EVA9 citations82
US8288385B2Oct 16, 2012
6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
CAROFF EVA7 citations82
US8058263B2Nov 15, 2011
Substituted 2-phenyl-pyridine derivatives
CAROFF EVA9 citations82
US8664203B2Mar 4, 2014
Thiazole derivatives and their use as P2Y12 receptor antagonists
CAROFF EVA4 citations71
ACTELION PHARMACEUTICALS LTD
4 patentsUS9388198B2Jul 12, 2016
Heterocyclic amide derivatives as P2X7 receptor antagonists
ACTELION PHARMACEUTICALS LTD0 citations51
US9718774B2Aug 1, 2017
Indole carboxamide derivatives as P2X7 receptor antagonist
ACTELION PHARMACEUTICALS LTD0 citations40
US9556117B2Jan 31, 2017
Indole carboxamide derivatives as P2X7 receptor antagonists
ACTELION PHARMACEUTICALS LTD0 citations40
US9388197B2Jul 12, 2016
Heterocyclic amide derivatives as P2X7 receptor antagonists
ACTELION PHARMACEUTICALS LTD0 citations40
IDORSIA PHARMACEUTICALS LTD
3 patentsUS11739070B2Aug 29, 2023
C5A receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations48
US11685729B2Jun 27, 2023
C5a receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations48
US11608341B2Mar 21, 2023
Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations48